Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
SATB2 encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. Zusätzlich bieten wir Ihnen SATB2 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 91 products:
Human Polyclonal SATB2 Primary Antibody für IHC, ELISA - ABIN1003122
Dickinson, Kohwi-Shigematsu: Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential. in Molecular and cellular biology 1995
Show all 4 Pubmed References
Human Polyclonal SATB2 Primary Antibody für IHC, ELISA - ABIN1003123
Szemes, Gyorgy, Paweletz, Dobi, Agoston: Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. in Neurochemical research 2006
Show all 4 Pubmed References
Human Polyclonal SATB2 Primary Antibody für ICC, IF - ABIN4352126
Ek, Andréasson, Hober, Kampf, Pontén, Uhlén, Merz, Borrebaeck: From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. in Molecular & cellular proteomics : MCP 2006
Show all 4 Pubmed References
Human Polyclonal SATB2 Primary Antibody für IP - ABIN315852
Liu, Xu, Yang, Zhong, Song, Li, Hu, Chen, Hu, Han, Zeng: Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients. in PLoS ONE 2012
Human Polyclonal SATB2 Primary Antibody für ICC, IF - ABIN4352127
Nodin, Johannesson, Wangefjord, OConnor, Lindquist, Uhlén, Jirström, Eberhard: Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. in Diagnostic pathology 2012
features associated with de novo mutations affecting SATB2 function in individuals ascertained on the basis of intellectual disability
The mRNA level of SATB2 was lower in tumor tissues than in samples of corresponding unchanged kidney. The results of the presented study suggest the tumor-suppressing function of SATB2.
MiR (zeige MLXIP Antikörper)-875-5pdirectly binds to the 3'untranslated region of SATB.2
These results strongly suggest that SATB2 prevents induction of EMT (zeige ITK Antikörper) by suppressing expression of EMT (zeige ITK Antikörper)-inducing transcription factors in NSCLC cells.
We describe here the identification of a de novo SATB2 point mutation in twin boys with cleft soft palate, dental anomalies, and development delay and compare the clinical presentation of SATB2 point mutation patients reported to date.
our data reveal that SATB2 in alveolar bone mesenchymal stem cells (AB-BMSCs) associates with their age-related properties, and prevents AB-BMSCs senescence via maintaining Nanog expression.
SATB2 is frequently expressed in appendiceal mucinous neoplasms. In the context of a mucinous neoplasm involving the ovary, any SATB2 positivity should raise the possibility of appendiceal origin.
our results strongly indicate that the crosstalk between p38 (zeige CRK Antikörper) and Akt (zeige AKT1 Antikörper) pathways can determine special AT-rich sequence-binding protein 2 expression and epithelial character of non-small-cell lung carcinoma cells
SATB2 immunohistochemistry is not useful in supporting urothelial versus gastrointestinal or endocervical origin in the differential diagnosis of glandular lesions of the bladder/urinary tract.
we report a exon frameshift mutation in SATB2 in a 15-year-old patient with cleft palate, apparent ID, mild facial dysmorphism, and low weight with additional features of osteoporosis, fractures, progressive tibial bowing, and scoliosis. it provides further evidence of a single-nucleotide, potentially dominant-negative SATB2 allele in association with phenotypes beyond those typically associated with deletion of the gene
Together, these findings demonstrate that Satb2 is critically involved in long-term plasticity processes in the adult forebrain that underlie the consolidation and stabilization of context-linked memory.
Satb2 is a genetic determinant that mediates proper circuit development in a core sensory-to-motor spinal network.
Data indicate two special AT-rich sequence-binding protein 2 (SATB2) sequence variants in two unrelated patients presenting with Rett-like phenotypes.
results suggest that expression of Sp7 (zeige SP7 Antikörper) during the early stage of Satb2-induced osteogenic differentiation of BMSCs is regulated by miR (zeige MLXIP Antikörper)-27a.
Data show that Satb2 is required by both callosal projection neurons and subcerebral projection neurons for proper differentiation and axon pathfinding.
Satb2 and Fezf2 (zeige FEZF2 Antikörper) regulation promotes subcerebral projection neuron identity in the developing cerebral cortex
Satb2 may also be related to the establishment of species-specific neuropeptide co-phenotypes during postnatal development.
Target genes of miR (zeige MLXIP Antikörper)-27a ware significantly up-regulated in Satb2-overexpressing cells.
A comprehensive overview of Satb2 expression in the adult mouse brain.
The Satb2 proteins are dispensable for X chromosome inactivation in mice.
This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and mental retardation. Alternate splicing results in multiple transcript variants that encode the same protein.
DNA-binding protein SATB2
, special AT-rich sequence-binding protein 2
, special AT-rich sequence binding protein
, SATB homeobox 2
, special AT-rich sequence binding protein 2
, SATB family member 2
, KIAA1034-like DNA binding protein
, two cut domains-containing homeodomain protein